Soleno Therapeutics, Inc.
US ˙ NasdaqCM ˙ US8342033094

Introduction

This page provides a comprehensive analysis of the known insider trading history of Frank Kung. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Frank Kung has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:AMRS / Amyris Inc Director 0
US:SGNT / Sagent Pharmaceuticals, Inc. Director 921
US:SLNO / Soleno Therapeutics, Inc. 10% Owner 945,200
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Frank Kung. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases SLNO / Soleno Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in SLNO / Soleno Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 1,936,843 193,684 731 0.9700
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 22,729 2,273
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 28,028 2,803
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 6,689 669
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 122 12
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 348,800 34,880
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 4,093 409
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 585,437 58,544
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 6,870 687

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SLNO / Soleno Therapeutics, Inc. Insider Trades
Insider Sales SLNO / Soleno Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in SLNO / Soleno Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SLNO / Soleno Therapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Frank Kung as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-05-07 2024-05-07 4 AMRS AMYRIS, INC.
Common Stock
J - Other -16,207 0 -100.00
2024-05-07 2024-05-07 4 AMRS AMYRIS, INC.
Common Stock
J - Other -938,416 0 -100.00
2024-05-07 2024-05-07 4 AMRS AMYRIS, INC.
Common Stock
J - Other -6,796,205 0 -100.00
2022-09-23 2022-09-21 4/A AMRS AMYRIS, INC.
Common Stock
S - Sale X -36,488 0 -100.00 3.50 -127,708
2022-09-23 2022-09-21 4/A AMRS AMYRIS, INC.
Common Stock
S - Sale X -163,512 0 -100.00 3.50 -572,292
2022-09-23 2022-09-20 4/A AMRS AMYRIS, INC.
Common Stock
S - Sale X -72,972 36,488 -66.67 3.60 -262,699 131,357
2022-09-23 2022-09-20 4/A AMRS AMYRIS, INC.
Common Stock
S - Sale X -327,028 163,512 -66.67 3.60 -1,177,301 588,643
2022-09-22 2022-09-21 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -36,488 0 -100.00 3.50 -127,708
2022-09-22 2022-09-21 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -163,512 0 -100.00 3.50 -572,292
2022-09-22 2022-09-20 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -72,972 36,488 -66.67 3.60 -262,699 131,357
2022-09-22 2022-09-20 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -327,028 163,512 -66.67 3.60 -1,177,301 588,643
2022-09-19 2022-09-19 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -197,148 109,460 -64.30 3.80 -749,162 415,948
2022-09-19 2022-09-19 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -883,528 490,540 -64.30 3.80 -3,357,406 1,864,052
2022-09-19 2022-09-16 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -151,983 306,608 -33.14 3.60 -547,139 1,103,789
2022-09-19 2022-09-16 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -681,117 1,374,068 -33.14 3.60 -2,452,021 4,946,645
2022-09-19 2022-09-15 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -252,667 458,591 -35.52 4.20 -1,061,201 1,926,082
2022-09-19 2022-09-15 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -1,132,333 2,055,185 -35.52 4.20 -4,755,799 8,631,777
2022-08-29 2022-08-23 4/A AMRS AMYRIS, INC.
Common Stock
J - Other 7,409 16,207 84.21
2022-08-29 2022-08-23 4/A AMRS AMYRIS, INC.
Common Stock
J - Other -7,409 80,000 -8.48
2022-08-29 2022-08-22 4/A AMRS AMYRIS, INC.
Common Stock
A - Award 80,000 87,409 1,079.77
2022-08-24 2022-08-22 4 AMRS AMYRIS, INC.
Common Stock
A - Award 80,000 80,000
2021-08-26 2021-08-23 4/A AMRS AMYRIS, INC.
Common Stock
A - Award 7,409 7,409
2021-08-25 2021-08-23 4 AMRS AMYRIS, INC.
Common Stock
A - Award 7,409 7,409
2021-08-09 2021-08-05 4 AMRS AMYRIS, INC.
Common Stock
J - Other 2,266 8,798 34.69
2021-08-09 2021-08-05 4 AMRS AMYRIS, INC.
Common Stock
J - Other -2,266 0 -100.00
2021-04-15 2021-04-14 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -147,111 0 -100.00 4.76 -700,248
2021-04-15 2021-04-14 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -1,065,676 0 -100.00 4.76 -5,072,618
2021-04-15 2021-04-14 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 147,111 938,416 18.59 4.76 700,248 4,466,860
2021-04-15 2021-04-14 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 1,065,676 6,796,205 18.60 4.76 5,072,618 32,349,936
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -1,005 0 -100.00
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -7,275 0 -100.00
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -286,032 711,258 -28.68 14.96 -4,279,754 10,642,198
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -1,281,858 3,187,518 -28.68 14.96 -19,179,800 47,693,238
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -377,384 791,305 -32.29 14.96 -5,646,608 11,839,901
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -2,733,089 5,730,529 -32.29 14.96 -40,893,844 85,743,040
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 235,829 1,168,689 25.28 4.26 1,004,632 4,978,615
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 1,707,830 8,463,618 25.28 4.26 7,275,356 36,055,013
2020-11-04 2020-11-02 4 AMRS AMYRIS, INC.
Common Stock
J - Other 666 6,532 11.35
2020-11-04 2020-11-02 4 AMRS AMYRIS, INC.
Common Stock
J - Other -666 2,266 -22.71
2020-10-27 2020-10-23 4 AMRS AMYRIS, INC.
Common Stock
J - Other 2,266 5,866 62.94
2020-10-27 2020-10-23 4 AMRS AMYRIS, INC.
Common Stock
J - Other -2,266 2,932 -43.59
2020-08-07 2020-08-05 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 3,466 3,466
2020-08-07 2020-08-05 4 AMRS AMYRIS, INC.
Common Stock
A - Award 2,266 5,198 77.29
2020-08-07 2020-08-05 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 3,466 3,466
2020-08-07 2020-08-05 4 AMRS AMYRIS, INC.
Common Stock
A - Award 2,266 5,198 77.29
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Series E Convertible Preferred Stock
P - Purchase 195 195 1,000.00 195,082 195,082
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Series E Convertible Preferred Stock
P - Purchase 1,336 1,336 1,000.00 1,336,216 1,336,216
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Series E Convertible Preferred Stock
P - Purchase 1,413 1,413 1,000.00 1,412,736 1,412,736
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Series E Convertible Preferred Stock
P - Purchase 5,988 5,988 1,000.00 5,988,286 5,988,286
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 551,884 551,884 3.00 1,655,652 1,655,652
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 80,573 867,832 10.23 3.00 241,719 2,603,496
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 2,473,280 2,473,280 3.00 7,419,840 7,419,840
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 583,488 6,284,876 10.23 3.00 1,750,464 18,854,628
2019-11-05 2019-11-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other 667 3,600 22.74
2019-11-05 2019-11-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other -667 2,932 -18.53
2019-10-25 2019-10-23 4 AMRS AMYRIS, INC.
Stock Option (Right to Buy)
A - Award 3,466 3,466
2019-10-25 2019-10-23 4 AMRS AMYRIS, INC.
Common Stock
A - Award 2,266 3,599 169.99
2019-08-05 2019-08-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other 2,266 2,933 339.73
2019-08-05 2019-08-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other -2,266 1,333 -62.96
2019-05-01 2019-04-29 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
P - Purchase 147,111 147,111 0.12 18,389 18,389
2019-05-01 2019-04-29 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
P - Purchase 1,065,676 1,065,676 0.12 133,210 133,210
2019-05-01 2019-04-29 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 110,811 787,259 16.38 4.76 527,460 3,747,353
2019-05-01 2019-04-29 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 802,718 5,701,388 16.39 4.76 3,820,938 27,138,607
2018-11-02 2018-11-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other 667 667
2018-11-02 2018-11-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other -667 3,599 -15.64
2018-08-24 2018-08-20 4/A AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 256,251 256,251
2018-08-24 2018-08-20 4/A AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 1,855,706 1,855,706
2018-08-24 2018-08-17 4/A AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 619,749 619,749
2018-08-24 2018-08-17 4/A AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 4,488,072 4,488,072
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 256,251 256,251
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 1,855,706 1,855,706
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -197,877 0 -100.00
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -1,432,977 0 -100.00
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 197,877 676,448 41.35 4.40 870,659 2,976,371
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 1,432,977 4,898,670 41.35 4.40 6,305,099 21,554,148
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -139,306 478,571 -22.55 6.22 -866,316 2,976,137
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -1,008,816 3,465,693 -22.55 6.22 -6,273,625 21,552,452
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 619,749 619,749
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 4,488,072 4,488,072
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
D - Sale to Issuer 0 0
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
D - Sale to Issuer 0 0
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -478,571 197,877 -70.75
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -3,465,693 1,432,977 -70.75
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Series D Convertible Preferred Stock
M - Exercise -568 1,005 -36.10
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Series D Convertible Preferred Stock
M - Exercise -4,111 7,275 -36.10
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 478,571 617,877 343.54 4.40 2,105,712 2,718,659
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 3,465,693 4,474,509 343.54 4.40 15,249,049 19,687,840
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -336,914 139,306 -70.75 6.22 -2,095,201 866,316
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -2,439,848 1,008,816 -70.75 6.22 -15,172,927 6,273,625
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 133,246 476,220 38.85 4.26 567,628 2,028,697
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 964,927 3,448,664 38.85 4.26 4,110,589 14,691,309
2018-08-03 2018-08-01 4 AMRS AMYRIS, INC.
Stock Option (Right to Buy)
A - Award 3,466 3,466
2018-08-03 2018-08-01 4 AMRS AMYRIS, INC.
Common Stock
A - Award 2,266 4,266 113.30
2017-11-08 2017-11-06 4 AMRS AMYRIS, INC.
Stock Option (Right to Buy)
A - Award 3,000 3,000
2017-11-08 2017-11-06 4 AMRS AMYRIS, INC.
Common Stock
A - Award 2,000 2,000
2017-11-08 3 AMRS AMYRIS, INC.
Common Stock
5,310,448
2017-11-08 3 AMRS AMYRIS, INC.
Common Stock
3,169,685
2017-11-08 3 AMRS AMYRIS, INC.
Common Stock
5,310,448
2017-11-08 3 AMRS AMYRIS, INC.
Common Stock
3,169,685
2015-04-13 2015-04-09 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 921 921
2015-02-27 2015-02-25 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 1,841 1,841
2015-02-24 2015-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -567 567 -50.00
2015-02-24 2015-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 567 36,909 1.56
2015-02-24 2015-02-21 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -760 1,520 -33.33
2015-02-24 2015-02-21 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 760 36,342 2.14
2015-02-20 2015-02-18 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -930 2,790 -25.00
2015-02-20 2015-02-18 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 930 35,582 2.68
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series A Warrant to Purchase Common Stock
P - Purchase 6,870 945,200 0.73
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Warrant to Purchase Common Stock
P - Purchase 6,870 945,200 0.73
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series A Warrant to Purchase Common Stock
P - Purchase 585,437 938,330 165.90
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Warrant to Purchase Common Stock
P - Purchase 585,437 938,330 165.90
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series A Warrant to Purchase Common Stock
P - Purchase 4,093 352,893 1.17
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Warrant to Purchase Common Stock
P - Purchase 4,093 352,893 1.17
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series A Warrant to Purchase Common Stock
P - Purchase 348,800 348,800
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Warrant to Purchase Common Stock
P - Purchase 348,800 348,800
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Warrant to Purchase Common Stock
J - Other 17 331,111 0.01
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Warrant to Purchase Common Stock
J - Other 1,002 331,094 0.30
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Warrant to Purchase Common Stock
J - Other 4,205 330,092 1.29
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Warrant to Purchase Common Stock
J - Other 3,778 325,887 1.17
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Warrant to Purchase Common Stock
J - Other 322,109 322,109
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series A Preferred Stock
C - Conversion -31,250 0 -100.00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Preferred Stock
C - Conversion -1,755 0 -100.00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Preferred Stock
C - Conversion -95,112 1,755 -98.19
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Preferred Stock
C - Conversion -19,766 96,867 -16.95
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series C Preferred Stock
C - Conversion -1,102 0 -100.00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series C Preferred Stock
C - Conversion -59,638 1,102 -98.19
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series C Preferred Stock
C - Conversion -178,408 64,740 -73.37
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series C Preferred Stock
C - Conversion -240 239,148 -0.10
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series C Preferred Stock
C - Conversion -137,277 239,388 -36.45
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2014 Convertible Promissory Notes
S - Sale -18,401 0 -100.00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2014 Convertible Promissory Notes
S - Sale -1,567,879 0 -100.00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2010/2012 Convertible Promissory Notes
S - Sale -596 0 -100.00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2010/2012 Convertible Promissory Notes
S - Sale -32,569 0 -100.00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2010/2012 Convertible Promissory Notes
S - Sale -136,441 0 -100.00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2010/2012 Convertible Promissory Notes
S - Sale -110,642 0 -100.00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2010/2012 Convertible Promissory Notes
S - Sale -9,427,595 0 -100.00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 6,870 3,497,288 0.20
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 585,437 3,490,418 20.15
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 4,093 2,904,981 0.14
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 348,800 2,900,888 13.67
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 122 2,552,088 0.00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 6,689 2,551,966 0.26
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 28,028 2,545,277 1.11
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 22,729 2,517,249 0.91
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 1,936,843 2,494,520 347.31
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 31,250 557,677 5.94
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 1,755 526,427 0.33
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 95,112 524,672 22.14
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 19,766 429,560 4.82
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 1,102 409,794 0.27
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 59,638 408,692 17.09
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 178,408 349,054 104.55
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 1,611 170,646 0.95
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 137,277 169,035 432.26
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52,390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31,855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52,390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31,855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52,390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31,855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52,390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31,855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52,390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31,855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52,390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31,855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52,390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31,855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52,390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31,855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52,390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31,855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52,390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31,855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52,390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37,059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31,855
2014-02-24 2014-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -567 1,134 -33.33
2014-02-24 2014-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 567 34,652 1.66
2014-02-24 2014-02-21 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -759 2,280 -24.98
2014-02-24 2014-02-21 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 759 34,085 2.28
2014-02-19 2014-02-18 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 3,720 3,720
2013-09-17 2013-09-16 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
S - Sale -622,700 4,180,791 -12.96 21.25 -13,232,375 88,841,809
2013-09-17 2013-09-16 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
S - Sale -539,017 3,618,946 -12.96 21.25 -11,454,111 76,902,602
2013-02-25 2013-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -567 1,701 -25.00
2013-02-25 2013-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 567 33,326 1.73
2013-02-25 2013-02-21 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 3,039 3,039
2012-06-04 2012-06-01 4 SGNT Sagent Pharmaceuticals, Inc.
Stock Option to Buy/Restricted Stock
M - Exercise -3,190 0 -100.00
2012-06-04 2012-06-01 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 3,190 32,759 10.79 4.23 13,494 138,571
2012-04-19 2011-06-01 4 SGNT Sagent Pharmaceuticals, Inc.
Stock Option to Buy/Restricted Stock
M - Exercise -3,190 3,189 -50.01
2012-04-19 2011-06-01 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 3,190 29,569 12.09 4.23 13,494 125,077
2012-02-24 2012-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 2,268 2,268
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)